Finance
PBM margins are priced; specialty spread is the proof
A finance thematic deep dive arguing that pharmacy benefit managers still have scale, claims volume, and specialty-pharmacy integration, but the 2026 proof is whether Evernorth, CVS Caremark, and Optum Rx can defend margins as specialty-generic spread, client pricing, Part D redesign, and regulatory scrutiny compress the old profit lanes.
Read article ->